HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 04, April 2018 – Digestive health in the 21st century - Trust your guts       » Food wasted in China could feed 30-50 million       » Chinese scientists analyze human brain's "CPU"       » $150,000 fundraiser launched to sequence South Asian genomes       » Green tea-based drug carriers improve cancer treatment       » Scientists grow liver cancer cells in lab      
BIOBOARD - NORTH AMERICA
“On Demand Medical Research” is up and running
Patients, frustrated by risks and inefficiencies of the current U.S. health system, have begun retaining private teams of doctors and medical researchers to deliver solutions. This is where MetaMed comes in. Accessed virtually, MetaMed services for personalized medical research is available in the U.S. and globally. MetaMed provides personalized medical breakthroughs by leveraging data-driven research and rational analysis of studies, in a package customized to fit the needs of patients and their doctors.

MetaMed's Chief Science Officer, Michael Vassar, explains: “Over 30% of fatal illnesses are missed during diagnosis, and this figure hasn’t changed since the 1930s. Cancer death rates have decreased by less than 5% over the past 40 years.”

These problems can be tackled by the continuing revolution towards personalized, evidence-based medicine. “The results of most published papers turn out to be false”, explains Alyssa Vance, President of MetaMed. “Their design is often flawed, and medical journals unfairly favor positive results over those that prove a treatment doesn't work. And many drugs only work on a fraction of the population, due to differences in individual biology. We help fix these problems with a rational approach to evaluating studies and developing treatments.”

Patients work with their current doctor, or are introduced to one by MetaMed. The team on-boards their entire medical history, and can examine the patient's genome, model their individual metabolic variations, understand their disease processes at the biochemical level, and locate targets for intervention. By looking at the entirety of the patient's health history, symptoms and test results, MetaMed is able to identify new connections between biological processes and their associated diseases.

Experts estimate there are nearly 100,000 preventable deaths annually in the U.S. alone, and the time it takes for new discoveries to actually reach patients can be up to thirty years, if at all. MetaMed, a start-up backed by PayPal co-founder and billionaire Peter Thiel and co-founded by Skype founder Jaan Tallinn, has begun accepting new patients who want to be certain they are getting the most effective and appropriate treatment.

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy